 |
市場調查報告書
商品編碼
2054877
鬱血性心臟衰竭市場（按類型分類）Congestive Heart Failure Market, By Type (Systolic Heart Failure, Diastolic Heart Failure, Acute Heart Failure, and Chronic Heart Failure, By Diagnosis, By Device Type, By Gender, By Age Group, By End User, By Geography ) |
||||||
價格
簡介目錄
2026年，鬱血性心臟衰竭市場規模估計為268億美元，預計2033年將達445億美元。預計從2026年到2033年，該市場將以7.5%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 268億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 7.50% | 2033年市場規模預測： | 445億美元 |
近年來，受心血管疾病患病率上升、老齡人口成長以及對有效治療方法的需求不斷增加的推動，全球鬱血性心臟衰竭（CHF）市場經歷了顯著成長。鬱血性心臟衰竭是一種慢性疾病，其特徵是心臟無法泵出足夠的血液來滿足身體的需求。由於先進診斷技術和創新治療方法的出現，CHF管理市場已顯著擴張。
市場動態：
全球鬱血性心臟衰竭）市場受多種因素驅動，包括心血管疾病盛行率上升、老年人口增加、久坐生活方式的盛行。人們對CHF早期診斷和治療重要性的認知不斷提高，也促進了市場成長。然而，部分地區高昂的治療費用和不完善的醫保報銷體係可能會抑制市場成長。此外，一些現有治療方法的副作用也可能阻礙市場成長。另一方面，基因療法和幹細胞療法等新型治療方法的開發，以及對個人化醫療日益成長的關注，為市場相關人員帶來了巨大的成長機會。未來幾年，製藥公司和研究機構在開發新治療方法加強合作，預計也將推動市場成長。
本研究的主要特點：
- 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
- 本研究根據以下參數對全球鬱血性心臟衰竭市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 這份全球鬱血性心臟衰竭市場報告面向產業內的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 透過對全球鬱血性心臟衰竭市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 機會
- 影響分析
- 主要進展
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 併購情景
- 產業趨勢
第4章 全球鬱血性心臟衰竭市場：依類型分類，2021-2033年
- 收縮性心臟衰竭
- 舒張性心衰竭
- 急性心臟衰竭
- 慢性心臟衰竭
第5章 全球鬱血性心臟衰竭市場：依診斷分類，2021-2033年
- 心臟超音波圖
- 胸部X光檢查
- 血液檢測（BNP、NT-proBNP）
- 心臟導管插入術
- 磁振造影
- 連續型心電圖監測
- 核子醫學掃描術診斷
第6章 全球鬱血性心臟衰竭市場：依器材類型分類，2021-2033年
- 心律調節器
- 植入式心臟整流去顫器（ICD）
- 心臟再同步治療（CRT）裝置
- 心室輔助裝置（VAD）
- 遠端監控設備
- 其他
第7章 全球鬱血性心臟衰竭市場：依性別分類，2021-2033年
- 男性
- 女士
第8章 全球鬱血性心臟衰竭市場：依年齡層別分類，2021-2033年
- 成人
- 兒童
- 老年人
第9章 全球鬱血性心臟衰竭市場：依最終用戶分類，2021-2033年
- 醫院
- 專科診所
- 門診手術中心
- 診斷中心
- 家庭醫療保健
- 學術研究機構
第10章 全球鬱血性心臟衰竭市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第11章 競爭格局
- Novartis
- Boehringer Ingelheim
- AstraZeneca
- Johnson & Johnson
- Abbott
- Medtronic
- Boston Scientific
- Pfizer
- Merck & Co
- Bristol Myers Squibb
- LivaNova
- Biotronik
- V-Wave
- Impulse Dynamics
- CVRx
第12章 分析師建議
- 機會分析
- 分析師意見
- Coherent Opportunity Map
第13章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI7922
Congestive Heart Failure Market is estimated to be valued at USD 26.80 Bn in 2026 and is expected to reach USD 44.50 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 26.80 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.50% | 2033 Value Projection: | USD 44.50 Bn |
The global congestive heart failure market has witnessed significant growth in recent years, driven by the increasing prevalence of cardiovascular diseases, the rising geriatric population, and the growing demand for effective treatment options. Congestive heart failure (CHF) is a chronic condition characterized by the heart's inability to pump sufficient blood to meet the body's needs. With the advent of advanced diagnostic techniques and innovative treatment approaches, the market for CHF management has expanded considerably.
Market Dynamic:
The global congestive heart failure market is driven by several factors, including the rising prevalence of cardiovascular diseases, the growing geriatric population, and the increasing adoption of sedentary lifestyles. The increasing awareness about the importance of early diagnosis and treatment of CHF have also contributed to the market growth. However, the high cost of treatment and the lack of reimbursement policies in some regions may restrain the market growth. Moreover, the side effects associated with some of the available treatment options may also hinder the market growth. On the other hand, the development of novel therapies, such as gene therapy and stem cell therapy, and the increasing focus on personalized medicine offer significant growth opportunities for the market players. Increasing collaborations between pharmaceutical companies and research institutes for the development of novel therapies are also expected to drive the market growth in the coming years.
Key Features of the Study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global congestive heart failure market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Novartis, Boehringer Ingelheim, AstraZeneca, Johnson & Johnson, Abbott, Medtronic, Boston Scientific, Pfizer, Merck & Co, Bristol Myers Squibb, LivaNova, Biotronik, V-Wave, Impulse Dynamics, and CVRx
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global congestive heart failure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global congestive heart failure market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Systolic Heart Failure
- Diastolic Heart Failure
- Acute Heart Failure
- Chronic Heart Failure
- Diagnosis Insights (Revenue, USD Bn, 2021 - 2033)
- Echocardiography
- Chest X-Ray
- Blood Tests (BNP, NT-proBNP)
- Cardiac Catheterization
- Magnetic Resonance Imaging
- Holter Monitoring
- Nuclear Imaging
- Device Type Insights (Revenue, USD Bn, 2021 - 2033)
- Pacemakers
- Implantable Cardioverter-Defibrillators (ICDs)
- Cardiac Resynchronization Therapy (CRT) Devices
- Ventricular Assist Devices (VADs)
- Remote Monitoring Devices
- Others
- Gender Insights (Revenue, USD Bn, 2021 - 2033)
- Male
- Female
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Adult
- Pediatrics
- Geriatric
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- Home Healthcare
- Academic and Research Institutes
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Novartis
- Boehringer Ingelheim
- AstraZeneca
- Johnson & Johnson
- Abbott
- Medtronic
- Boston Scientific
- Pfizer
- Merck & Co
- Bristol Myers Squibb
- LivaNova
- Biotronik
- V-Wave
- Impulse Dynamics
- CVRx
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Congestive Heart Failure Market, By Type
- Global Congestive Heart Failure Market, By Diagnosis
- Global Congestive Heart Failure Market, By Device Type
- Global Congestive Heart Failure Market, By Gender
- Global Congestive Heart Failure Market, By Age Group
- Global Congestive Heart Failure Market, By End User
- Global Congestive Heart Failure Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Congestive Heart Failure Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Systolic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diastolic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Acute Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chronic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Congestive Heart Failure Market, By Diagnosis, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Echocardiography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chest X-Ray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Blood Tests (BNP, NT-proBNP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiac Catheterization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Magnetic Resonance Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Holter Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nuclear Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Congestive Heart Failure Market, By Device Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pacemakers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Implantable Cardioverter-Defibrillators (ICDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiac Resynchronization Therapy (CRT) Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ventricular Assist Devices (VADs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Remote Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Congestive Heart Failure Market, By Gender, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Congestive Heart Failure Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Congestive Heart Failure Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Congestive Heart Failure Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LivaNova
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biotronik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- V-Wave
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Impulse Dynamics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CVRx
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
鬱血性心臟衰竭治療藥物市場規模、佔有率和成長分析：按藥物類別、給藥途徑、適應症、分銷管道、最終用戶、患者類型和地區分類－2026-2033年產業預測
鬱血性心臟衰竭治療市場：依藥物類別、給藥途徑、通路和地區分類（2026-2034 年）
鬱血性心臟衰竭市場：2026-2032年全球市場預測（依治療方法、疾病、給藥途徑、病患群體、醫療機構、最終用戶和分銷管道分類）
2026-2034年全球鬱血性心臟衰竭治療市場規模、佔有率、趨勢和成長分析報告
充血性心臟衰竭藥物市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）
鬱血性心臟衰竭藥物市場規模、佔有率、趨勢分析報告：按藥物、產品、通路、地區、細分市場預測，2024-2030年